# Trump Media & Technology Group Corp.: financial statements, quarterly

DJT · Nasdaq · CIK 1849635 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/djt.md) · [Financials](/companies/djt/financials.md) · [Filings](/companies/djt/filings.md) · [Insiders](/companies/djt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/djt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.1](/filings/0001140361-24-045260.md) | [0.8 d](/filings/0001140361-26-007174.md) | [0.8](/filings/0001140361-25-018209.md) | [0.8](/filings/0001140361-25-028418.md) | [1.0](/filings/0001140361-25-040977.md) | [1.0 d](/filings/0001140361-26-007174.md) | [0.8](/filings/0001140361-26-020229.md) | [0.9](/filings/0001437749-26-026777.md) | [1.0](/filings/0001140361-25-040977.md) | [1.0 d](/filings/0001140361-26-007174.md) | [0.9](/filings/0001140361-26-020229.md) | [1.7](/filings/0001437749-26-026777.md) |
| Cost of revenue | $m | [0.0](/filings/0001140361-24-045260.md) | [0.0 d](/filings/0001140361-26-007174.md) | [0.1](/filings/0001140361-25-018209.md) | [0.0](/filings/0001140361-25-028418.md) | [0.1](/filings/0001140361-25-040977.md) | [0.4 d](/filings/0001140361-26-007174.md) | [0.3](/filings/0001140361-26-020229.md) | [0.3](/filings/0001140361-25-028418.md) | [0.4](/filings/0001140361-25-040977.md) | [0.5 d](/filings/0001140361-26-007174.md) | [1.5](/filings/0001140361-26-020229.md) | not reported |
| Gross profit | $m | not reported | not reported | [0.7](/filings/0001140361-24-026889.md) | [0.8](/filings/0001140361-24-036633.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [2.2](/filings/0001140361-24-045260.md) | [2.5 d](/filings/0001140361-26-007174.md) | [33.2](/filings/0001140361-25-018209.md) | [4.9](/filings/0001140361-25-028418.md) | [3.9](/filings/0001140361-25-040977.md) | [7.2 d](/filings/0001140361-26-007174.md) | [12.6](/filings/0001140361-26-020229.md) | [13.0](/filings/0001437749-26-026777.md) | [8.3](/filings/0001140361-25-040977.md) | [8.9 d](/filings/0001140361-26-007174.md) | [8.4](/filings/0001140361-26-020229.md) | [8.2](/filings/0001437749-26-026777.md) |
| Selling, general and administrative | $m | [1.5](/filings/0001140361-24-045260.md) | [3.2 d](/filings/0001140361-26-007174.md) | [64.8](/filings/0001140361-25-018209.md) | [13.4](/filings/0001140361-25-028418.md) | [17.7](/filings/0001140361-25-040977.md) | [34.7 d](/filings/0001140361-26-007174.md) | [25.2](/filings/0001140361-26-020229.md) | [28.6](/filings/0001140361-25-028418.md) | [31.1](/filings/0001140361-25-040977.md) | [34.3 d](/filings/0001140361-26-007174.md) | [37.9](/filings/0001140361-26-020229.md) | not reported |
| Operating income | $m | [(3.0)](/filings/0001140361-24-045260.md) | [(5.3) d](/filings/0001140361-26-007174.md) | [(98.4)](/filings/0001140361-25-018209.md) | [(18.7)](/filings/0001140361-25-028418.md) | [(23.7)](/filings/0001140361-25-040977.md) | [(45.4) d](/filings/0001140361-26-007174.md) | [(39.5)](/filings/0001140361-26-020229.md) | [(43.5)](/filings/0001437749-26-026777.md) | [(57.7)](/filings/0001140361-25-040977.md) | [(432) d](/filings/0001140361-26-007174.md) | [(293)](/filings/0001140361-26-020229.md) | [(164)](/filings/0001437749-26-026777.md) |
| Interest expense | $m | [15.1](/filings/0001140361-24-045260.md) | [1.7 d](/filings/0001140361-26-007174.md) | [2.8](/filings/0001140361-25-018209.md) | [(0.2)](/filings/0001140361-25-028418.md) | [0.2](/filings/0001140361-25-040977.md) | [0.2 d](/filings/0001140361-26-007174.md) | [0.2](/filings/0001140361-26-020229.md) | [4.1](/filings/0001140361-25-028418.md) | [11.5](/filings/0001140361-25-040977.md) | [11.6 d](/filings/0001140361-26-007174.md) | [11.5](/filings/0001140361-26-020229.md) | [11.7](/filings/0001437749-26-026777.md) |
| Income tax | $m | [0.0](/filings/0001140361-24-045260.md) | [0.0 d](/filings/0001140361-26-007174.md) | [0.0](/filings/0001140361-25-018209.md) | [0.0](/filings/0001140361-25-028418.md) | [0.0](/filings/0001140361-25-040977.md) | [0.0 d](/filings/0001140361-26-007174.md) | [0.0](/filings/0001140361-26-020229.md) | [0.3](/filings/0001437749-26-026777.md) | [0.1](/filings/0001140361-25-040977.md) | [0.2 d](/filings/0001140361-26-007174.md) | [0.1](/filings/0001140361-26-020229.md) | [0.1](/filings/0001437749-26-026777.md) |
| Net income | $m | [(26.0)](/filings/0001140361-24-045260.md) | [(9.2)](/filings/0001140361-24-026889.md) | [(328)](/filings/0001140361-25-018209.md) | [(16.4)](/filings/0001140361-24-045260.md) | [(19.2)](/filings/0001140361-24-045260.md) | [(37.6) d](/filings/0001140361-25-004822.md) | [(31.7)](/filings/0001140361-25-018209.md) | [(20.0)](/filings/0001437749-26-026777.md) | [(54.8)](/filings/0001140361-25-040977.md) | [(606) d](/filings/0001140361-26-007174.md) | [(406)](/filings/0001437749-26-026777.md) | [(238)](/filings/0001437749-26-026777.md) |
| Diluted EPS | $ per share | [(0.30)](/filings/0001140361-24-045260.md) | not reported | [(3.61)](/filings/0001140361-25-018209.md) | [(0.10)](/filings/0001140361-25-028418.md) | [(0.10)](/filings/0001140361-25-040977.md) | not reported | [(0.14)](/filings/0001140361-26-020229.md) | [(0.08)](/filings/0001437749-26-026777.md) | [(0.20)](/filings/0001140361-25-040977.md) | not reported | [(1.47)](/filings/0001140361-26-020229.md) | [(0.86)](/filings/0001437749-26-026777.md) |
| Basic EPS | $ per share | [(0.30)](/filings/0001140361-24-045260.md) | not reported | [(3.61)](/filings/0001140361-25-018209.md) | [(0.10)](/filings/0001140361-25-028418.md) | [(0.10)](/filings/0001140361-25-040977.md) | not reported | [(0.14)](/filings/0001140361-26-020229.md) | [(0.08)](/filings/0001437749-26-026777.md) | [(0.20)](/filings/0001140361-25-040977.md) | not reported | [(1.47)](/filings/0001140361-26-020229.md) | [(0.86)](/filings/0001437749-26-026777.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.3](/filings/0001193125-23-282305.md) | [2.6](/filings/0001140361-26-007174.md) | [234](/filings/0001140361-25-018209.md) | [344](/filings/0001140361-25-028418.md) | [372](/filings/0001140361-25-040977.md) | [170](/filings/0001140361-26-007174.md) | [146](/filings/0001140361-26-020229.md) | [1,344](/filings/0001437749-26-026777.md) | [166](/filings/0001140361-25-040977.md) | [135](/filings/0001437749-26-026777.md) | [249](/filings/0001140361-26-020229.md) | [215](/filings/0001437749-26-026777.md) |
| Current assets | $m | [3.3](/filings/0001193125-23-282305.md) | [3.0](/filings/0001140361-25-004822.md) | [274](/filings/0001140361-24-026889.md) | [354](/filings/0001140361-24-036633.md) | [682](/filings/0001140361-24-045260.md) | [784](/filings/0001140361-26-007174.md) | [767](/filings/0001140361-25-018209.md) | [3,097](/filings/0001140361-25-028418.md) | [1,650](/filings/0001140361-25-040977.md) | [1,203](/filings/0001437749-26-026777.md) | [1,052](/filings/0001140361-26-020229.md) | [949](/filings/0001437749-26-026777.md) |
| Total assets | $m | [310](/filings/0001193125-23-282305.md) | [3.4](/filings/0001140361-25-004822.md) | [274](/filings/0001140361-24-026889.md) | [356](/filings/0001140361-24-036633.md) | [838](/filings/0001140361-24-045260.md) | [938](/filings/0001140361-26-007174.md) | [919](/filings/0001140361-25-018209.md) | [3,247](/filings/0001140361-25-028418.md) | [3,265](/filings/0001140361-25-040977.md) | [2,630](/filings/0001437749-26-026777.md) | [2,236](/filings/0001140361-26-020229.md) | [2,019](/filings/0001437749-26-026777.md) |
| Current liabilities | $m | [53.8](/filings/0001193125-23-282305.md) | [65.3](/filings/0001140361-25-004822.md) | [64.0](/filings/0001140361-24-026889.md) | [14.3](/filings/0001140361-24-036633.md) | [14.4](/filings/0001140361-24-045260.md) | [17.3](/filings/0001140361-26-007174.md) | [20.0](/filings/0001140361-25-018209.md) | [23.4](/filings/0001140361-25-028418.md) | [38.6](/filings/0001140361-25-040977.md) | [980](/filings/0001437749-26-026777.md) | [980](/filings/0001140361-26-020229.md) | [993](/filings/0001437749-26-026777.md) |
| Total liabilities | $m | [63.8](/filings/0001193125-23-282305.md) | [70.1](/filings/0001140361-25-004822.md) | [64.2](/filings/0001140361-24-026889.md) | [14.8](/filings/0001140361-24-036633.md) | [21.2](/filings/0001140361-24-045260.md) | [24.7](/filings/0001140361-26-007174.md) | [27.2](/filings/0001140361-25-018209.md) | [965](/filings/0001140361-25-028418.md) | [987](/filings/0001140361-25-040977.md) | [983](/filings/0001437749-26-026777.md) | [983](/filings/0001140361-26-020229.md) | [996](/filings/0001437749-26-026777.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [939](/filings/0001140361-25-028418.md) | [946](/filings/0001140361-25-040977.md) | [0.4](/filings/0001437749-26-026777.md) | [0.5](/filings/0001140361-26-020229.md) | [0.5](/filings/0001437749-26-026777.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001140361-25-004822.md) | not reported | not reported | [4.7](/filings/0001140361-24-045260.md) | [4.8](/filings/0001140361-25-040977.md) | [4.9](/filings/0001140361-25-018209.md) | [5.0](/filings/0001140361-25-028418.md) | [4.7](/filings/0001140361-25-040977.md) | [947](/filings/0001140361-26-007174.md) | [958](/filings/0001140361-26-020229.md) | [970](/filings/0001437749-26-026777.md) |
| Shareholders' equity | $m | [(57.6)](/filings/0001140361-24-045260.md) | [(66.8)](/filings/0001140361-25-018209.md) | [210](/filings/0001140361-25-018209.md) | [342](/filings/0001140361-24-045260.md) | [817](/filings/0001140361-24-045260.md) | [914](/filings/0001140361-26-007174.md) | [892](/filings/0001140361-25-018209.md) | [2,282](/filings/0001140361-25-028418.md) | [2,278](/filings/0001140361-25-040977.md) | [1,647](/filings/0001437749-26-026777.md) | [1,253](/filings/0001140361-26-020229.md) | [1,023](/filings/0001437749-26-026777.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.1) d](/filings/0001140361-24-045260.md) | [0.7 d](/filings/0001140361-26-007174.md) | [(9.3)](/filings/0001140361-25-018209.md) | [(21.4) d](/filings/0001140361-25-028418.md) | [(21.9) d](/filings/0001140361-25-040977.md) | [(8.3) d](/filings/0001140361-26-007174.md) | [(9.7)](/filings/0001140361-26-020229.md) | [2.3 d](/filings/0001437749-26-026777.md) | [10.1 d](/filings/0001140361-25-040977.md) | [12.1 d](/filings/0001140361-26-007174.md) | [17.9](/filings/0001140361-26-020229.md) | [(31.6) d](/filings/0001437749-26-026777.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001140361-24-045260.md) | [0.0 d](/filings/0001140361-26-007174.md) | [0.0](/filings/0001140361-25-018209.md) | [2.1 d](/filings/0001140361-25-028418.md) | [2.9 d](/filings/0001140361-25-040977.md) | [0.0 d](/filings/0001140361-26-007174.md) | [0.0](/filings/0001140361-26-020229.md) | [0.6 d](/filings/0001437749-26-026777.md) | [0.0 d](/filings/0001140361-25-040977.md) | [0.0 d](/filings/0001140361-26-007174.md) | [0.0](/filings/0001140361-26-020229.md) | [0.0 d](/filings/0001437749-26-026777.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001140361-26-007174.md) | [0.0](/filings/0001140361-25-018209.md) | [0.0 d](/filings/0001140361-25-028418.md) | [2.9 d](/filings/0001140361-25-040977.md) | [0.0 d](/filings/0001140361-26-007174.md) | [8.3](/filings/0001140361-26-020229.md) | [0.0 d](/filings/0001437749-26-026777.md) | [6.4 d](/filings/0001140361-25-040977.md) | [38.9 d](/filings/0001140361-26-007174.md) | [0.0](/filings/0001140361-26-020229.md) | [0.0 d](/filings/0001437749-26-026777.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [87.5](/filings/0001140361-24-026889.md) | [87.5](/filings/0001140361-24-036633.md) | [87.5](/filings/0001140361-24-045260.md) | [90.7](/filings/0001140361-25-018209.md) | [167](/filings/0001140361-25-028418.md) | [201](/filings/0001140361-25-040977.md) | [221](/filings/0001140361-26-020229.md) | [241](/filings/0001437749-26-026777.md) | [278](/filings/0001140361-25-040977.md) | [277](/filings/0001140361-26-020229.md) | [277](/filings/0001437749-26-026777.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 277,941,274 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001437749-26-026777.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.